Euclidean Capital LLC Surrozen, Inc. Transaction History

Euclidean Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 01, 2023	BUY	$0.44 - $0.89 $225,500 - $456,125	512,500 Added 63.83%	1,315,463 $644,000
Q1 2022 May 16, 2022	SELL	$2.2 - $6.01 $2 - $6	-1 Reduced -0.0%	802,963 $2.42 Million
Q4 2021 Feb 14, 2022	SELL	$6.0 - $9.92 $6 - $9	-1 Reduced -0.0%	802,964 $5.17 Million
Q3 2021 Nov 15, 2021	BUY	$6.98 - $12.03 $5.6 Million - $9.66 Million	802,965 New	802,965 $5.69 Million

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $342M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Euclidean Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Euclidean Capital LLC with notifications on news.